Kern Institute

Publications

• Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.

  (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ.) Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):979-986 PMID: 32599030 SCOPUS ID: 2-s2.0-85089292279 07/01/2020

• 'Knowing What's Best': Community Partnerships Against COVID-19.

  (Abenoza N, Hernandez C, Martinez E, Mora J, Siker M.) WMJ. 2020 06;119(2):76 PMID: 32659055 SCOPUS ID: 2-s2.0-85088026325 07/14/2020

• Lessons From COVID-19: Addressing Health Equity in Cancer Care

  (Siker ML, Deville C, Suneja G, Winkfield K.) International Journal of Radiation Oncology Biology Physics. 1 October 2020;108(2):475-478 SCOPUS ID: 2-s2.0-85090023271 10/01/2020

• Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting

  (Suneja G, Mattes MD, Mailhot Vega RB, Escorcia FE, Lawton C, Greenberger J, Kesarwala AH, Spektor A, Vikram B, Deville C, Siker M.) Advances in Radiation Oncology. 2020 SCOPUS ID: 2-s2.0-85087028121 01/01/2020

• Improving the Clinical Treatment of Vulnerable Populations in Radiation Oncology

  (McClelland S, Petereit DG, Zeitlin R, Takita C, Suneja G, Miller RC, Deville C, Siker ML.) Advances in Radiation Oncology. 2020 SCOPUS ID: 2-s2.0-85090061444 01/01/2020

• Halfway Toward Half Full.

  (Siker M, Kavanagh BD.) Int J Radiat Oncol Biol Phys. 2019 08 01;104(5):997-998 PMID: 31327431 SCOPUS ID: 2-s2.0-85068834659 07/23/2019

• Erratum: Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville Jr C: Achieving Gender Equity in the Radiation Oncology Physician Workforce (Advances in Radiation Oncology 2018;3:478-483).

  (.) Adv Radiat Oncol. 2019 Jan-Mar;4(1):210 PMID: 30706030 PMCID: PMC6349640 02/02/2019

• Achieving gender equity in the radiation oncology physician workforce.

  (Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville C Jr.) Adv Radiat Oncol. 2018 Oct-Dec;3(4):478-483 PMID: 30370345 PMCID: PMC6200884 10/30/2018

• Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review.

  (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA.) Neurosurgery. 2018 05 01;82(5):595-603 PMID: 29669114 SCOPUS ID: 2-s2.0-85068839760 04/19/2018

• Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.

  (Dhakal B, Fenske TS, Ramalingam S, Shuff J, Epperla N, Hosking P, Rein L, Banerjee A, Hari P, D'Souza A, Shah N, Siker M, Griepentrog GJ, Harris GJ, Wells TS, Erickson BA, Hamadani M.) Clin Lymphoma Myeloma Leuk. 2017 05;17(5):305-311.e2 PMID: 28284742 SCOPUS ID: 2-s2.0-85015693044 03/13/2017

• Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique.

  (Siker ML, Firat S, Prah D, Schultz CJ, Dayal A, Masterson C, Connelly JM, Mueller WM, Bovi JA.) Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E125-E126 PMID: 27673841 09/28/2016

• Clinical Significance of Updated MRI Simulation Versus Immediate Postoperative MRI for Radiation Treatment Planning in Patients With Glioblastoma: Changes in FLAIR Signal.

  (Dayal A, Siker ML, Firat S, Bovi JA, Schultz CJ, Mueller WM, Connelly JM, Rand SD.) Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E103 PMID: 27673785 09/28/2016